Enthusiasts say high-temperature sessions sharpen focus, improve health, and offer a chance to build contacts. It’s a far cry ...

Turning to the analyst community, Needham’s Chad Messer tells clients that he has high hopes ahead of the February 15 PDUFA date for trilaciclib, its therapy designed to improve outcomes for ...

Lake Street analyst Chad Messer initiated coverage of Immunome (IMNM) with a Buy rating and $23 price target The company’s lead clinical program, varegacestat for desmoid tumors, is not an ...

Messer, Jack, A. age 80 passed away on April 3rd, 2024, beloved husband of Nancy Messer, caring father of Chad (Shilpa) Messer and Douglas (Erica) Messer, dear brother of the late Frank (Barbara ...

Shares of the U.S.-listed Chinese immuno-oncology company I-Mab (NASDAQ: IMAB) offer strong upside potential, according to a Needham analyst. The I-Mab Analyst: Chad Messer initiated coverage of I ...

Chad Messer, a home resources coordinator for NECCO, an agency that helps CPS find foster homes for children, says there are not enough foster homes to meet the demand right now.

Super flyweight prospect Marisa Messer-Belenchia and undefeated featherweight prospect Tramaine Williams got special proclamations and former three-time light heavyweight world champion Chad Dawson ...

While the company, Sarepta Therapeutics, hailed the results as positive, they apparently were not positive enough for investors, who dumped the stock when markets opened. Chad Messer, an analyst ...

On a beautiful autumn day, one day after a thunderstorm drenched the area and kept people indoors, Old Greenwich resident Chad Messer relished the chance to take his three daughters outside Sunday ...

"We believe the timing of the deal reflects Amgen's confidence in the program," Needham's Chad Messer says of yesterday's strategic collaboration expansion between Cytokinetics (NASDAQ: CYTK) and ...

“Sweat equity takes on a whole new meaning when you’re networking in a hot room,” says Chad Messer, a managing director at US ...